LONGO, ANNA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 517
EU - Europa 354
AS - Asia 172
AF - Africa 63
SA - Sud America 37
Totale 1.143
Nazione #
US - Stati Uniti d'America 503
IT - Italia 227
SG - Singapore 100
IE - Irlanda 60
CN - Cina 59
CI - Costa d'Avorio 42
BR - Brasile 31
SN - Senegal 18
DE - Germania 16
FI - Finlandia 13
RU - Federazione Russa 11
CA - Canada 10
CH - Svizzera 6
SE - Svezia 6
AR - Argentina 5
GB - Regno Unito 5
UA - Ucraina 5
IN - India 4
MX - Messico 4
BD - Bangladesh 2
CZ - Repubblica Ceca 2
FR - Francia 2
NG - Nigeria 2
VN - Vietnam 2
AM - Armenia 1
GR - Grecia 1
IL - Israele 1
JP - Giappone 1
LB - Libano 1
PY - Paraguay 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 1.143
Città #
Santa Clara 125
Chandler 116
Singapore 69
Dublin 57
Chicago 54
Catania 49
Abidjan 42
Civitanova Marche 24
Rome 20
Boardman 19
Dakar 18
Andover 13
Ashburn 13
Cambridge 13
Lawrence 13
Helsinki 11
Jacksonville 10
Los Angeles 9
Nanjing 9
Palermo 8
Munich 7
Padova 7
Messina 6
Naples 6
Toronto 6
Des Moines 5
Wilmington 5
Buenos Aires 4
Council Bluffs 4
Hefei 4
Bremen 3
Casaleone 3
Milan 3
Misterbianco 3
Moscow 3
Ottawa 3
Pozzallo 3
Seattle 3
Abuja 2
Aci Castello 2
Atripalda 2
Augusta 2
Bari 2
Brno 2
Cagliari 2
Changsha 2
Dhaka 2
Dong Ket 2
Guangzhou 2
Hebei 2
Lappeenranta 2
Marano Principato 2
Montesilvano Marina 2
Natal 2
Pau dos Ferros 2
Rio de Janeiro 2
Santa Venerina 2
São Paulo 2
Tianjin 2
Turin 2
Veracruz 2
Aci Catena 1
Aci Sant'Antonio 1
Basel 1
Belo Horizonte 1
Berlin 1
Brasília 1
Bronte 1
Calgary 1
Campinas 1
Canosa di Puglia 1
Copertino 1
Corrientes 1
Cuiabá 1
Culiacán 1
Duartina 1
Duleek 1
Enshi 1
Falkenstein 1
Flint 1
Goiânia 1
Gosport 1
Grafing 1
Haifa 1
Horley 1
Itajaí 1
Itanhaém 1
Itapagipe 1
Johannesburg 1
Khabarovsk 1
Laojunmiao 1
Leawood 1
London 1
Manaus 1
Marsala 1
Matozinhos 1
Medianeira 1
Mexico City 1
Mogi Guaçu 1
Monmouth Junction 1
Totale 855
Nome #
CHI3L1 and CHI3L2 overexpression in motor cortex and spinal cord of sALS patients 99
Glucose-impaired Corneal Re-epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate 90
Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma 88
Gene nuclear positioning in leukaemia with chromosome 7 rearrangements 80
Effects of high glucose concentration on pericyte-like differentiated human adipose-derived mesenchymal stem cells 80
Somatic mosaicism with reversion to normality of a mutated transthyretin allele related to a familial amyloidotic polyneuropathy 78
Anti-angiogenic and anti-proliferative graphene oxide nanosheets for tumor cell therapy 72
Nuclear Repositioning of the Non-Translocated HLXB9 Allele in the Leukaemia Cell Line GDM-1 Harbouring a t(6;7)(q23;q36) 71
Pericytes in microvessels: From “mural” function to brain and retina regeneration 70
Topical administration of melatonin-loaded lipid-polymer hybrid nanoparticles for posterior segment eye diseases 70
Vitamin D3 preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy 69
Potential therapeutic applications of mesenchymal stem cells for the treatment of eye diseases 63
HLXB9 expression is independent from its nuclear gene positioning in breast cancer cells 61
Somatic mosaicism with reversion to normality of a mutated transthyretin allele related to a familial amyloidotic polyneuropathy 54
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine 52
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting 42
Analisi dell espressione delle Chitinasi e dei geni ad esse correlati nei soggetti esposti ad agenti inquinanti e al fumo di sigaretta 36
Ixazomib inhibits osteoclastogenesis and promotes osteogenic differentiation in vitro 19
Investigation of Serum Albumin as a Dynamic Treatment-Specific Surrogate for Outcomes in Patients With Myelofibrosis Treated With Ruxolitinib 5
Totale 1.199
Categoria #
all - tutte 4.739
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.739


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 0 0 0 0 4 3
2020/202130 1 0 2 0 7 2 4 0 3 0 7 4
2021/2022161 16 17 7 10 20 6 32 16 4 3 3 27
2022/2023287 22 26 10 25 34 36 8 54 54 3 8 7
2023/2024155 7 40 3 3 5 41 3 13 3 8 16 13
2024/2025477 14 97 28 51 100 70 38 12 30 32 5 0
Totale 1.199